Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...

With iPSCs, you can pick the cells from one donor, reprogram them, identify the best clone and then you have access to a stable iPSC line that you can use forever. Therefore, providing an endless ...

Two clonal lines are available for cell therapy developers and pharmaceutical companies as off-the-shelf products in both GMP and research-grade. (PRNewsfoto/I Peace, Inc.) I Peace's new iPSC line ...

Obviously, this is not an option in humans. “The only thing you can do for human iPSCs is take that cell line and put it into a teratoma assay in a mouse, and ask if the tumor tissues that form ...

Human iPSCs are a new type of pluripotent cell reprogrammed from patient or donor cells into versatile stem cells that can become any cell type. These iPSC-derived cells, which retain disease ...

A new era of cell therapy has well and truly arrived with the iPSC field setting a trailblazing fire with its potential to develop fully scalable, off-the-shelf cell lines reducing the cost of ...

adding skin and human retinal iPSC-derived cell lines to its existing neuroscience, pain and touch, and cardiovascular products and services. Phenocell's offering includes market-leading human ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...

Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant ...

and iPSC-derived cell therapies, announced that the company has successfully generated iPS cell lines that are homozygous for HLA A, C, and DPA1. Two clonal lines are available for cell therapy ...